XXXX in the control of postpartum @entity548 .

@entity1 @entity398 @entity29484 @entity548 @entity190 @entity1421 @entity6002
A @entity1421 analogue, @entity6002 was administered to control the postpartum @entity548 , immediately after the baby was born, to 74 healthy @entity1 , who had normal pregnancy and delivery. Divided into three groups they received 50 or 100 micrograms intravenously, or 200 micrograms intramuscularly. The results were compared with those of a group of 54 @entity1 , which received 0.2 mg @entity29484 i.m. and 5 IU @entity398 i.v. respectively. The @entity190 was measured during the third stage of labour and during two hours thereafter. The pilot dose of 50 micrograms was not effective enough. The @entity190 in the group of 100 micrograms i.v. was 386 +/- 175 ml, in the group of 200 micrograms i.m. 325 +/- 197 ml, and in the @entity29484 - @entity398 group 302 +/- 202 ml. @entity6002 200 micrograms i.m. seems to be effective treatment to control the postpartum @entity548 . Only four @entity1 had mild side-effects after @entity6002 administration.
